The U.S. Food and Drug Administration on Friday approved Stemline Therapeutics Inc's Elzonris for the treatment of a rare blood disease in adults and children aged two years and above.
from Reuters: Health https://reut.rs/2BDVa4e
U.S. FDA approves Stemline Therapeutics' rare blood disease treatment
Reviewed by RK Creations
on
December 22, 2018
Rating: 5
No comments